HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Lung Cancer Res
Main Authors: Yamaoka, Toshimitsu, Tsurutani, Junji, Sagara, Hironori, Ohmori, Tohru
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2020
Teme:
Editorial Commentary
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7653124/
https://ncbi.nlm.nih.gov/pubmed/33209639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-578
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki